News and Events

Latest News

Arquer Diagnostics @Arquer Diagnostics
We have some exciting news to share. The initial trial of #ADXGYNAE, our diagnostic test for #endometrialcancer, has yielded some extremely positive #results, demonstrating high sensitivity and NPV. We now hope to conduct larger #studies in Europe and the US. https://t.co/N08I6G0TXn

- 4 days ago

1
Arquer Diagnostics @Arquer Diagnostics
We use our proprietary MCM5 technology to develop non-invasive urine tests to aid the #cancer diagnosis pathway. At present, we have tests for #bladder, #prostate and #endometrial cancer at various stages of development and strive to make these available to patients everywhere. https://t.co/GayylCUA2p

- 13 days ago

1 1
Arquer Diagnostics @Arquer Diagnostics
By making use of our innovative MCM5-based technology, #ADXGYNAE strives to rule out the presence of #endometrialcancer in women presenting with the symptoms of this condition. This will reduce the number of #hysteroscopies performed on patients throughout the world. https://t.co/BPJ6WRSm7Z

- 34 days ago

1
Arquer Diagnostics @Arquer Diagnostics
#Ageist attitudes can seriously undermine modern #business. Our CEO Nadia Whittley tackles this age-based bias in her latest article: https://t.co/WzcSb3xt4q https://t.co/c50gi7gw13

- 39 days ago

1 3
Arquer Diagnostics @Arquer Diagnostics
The #PSAtest can diagnose patients with #prostatecancer. Yet, as around 15% of men with normal PSA levels may actually have this condition, this can go undetected. #ADXPROSTATE is currently undergoing a clinical study to determine its accuracy in detecting prostate cancer. https://t.co/8Vaf2Qkjc4

- 44 days ago

1 1
arquer diagnostics

A Fantastic Year For Arquer

2019 has definitely been a transformational year for the biotech industry! From genome editing to byonic organisms, innovation has pushed ...
Read More
arquer diagnostics

Innovation That Never Sleeps

The Start of Non-Invasive Testing When Arquer Diagnostics was set up to research and develop a new innovative urine test ...
Read More

Arquer Diagnostics achieves ISO13485 certification from BSI

In alignment with its commitment to achieving and maintaining excellence for patients, clinicians and all partners. BSI is an internationally ...
Read More

ADXBLADDER: A Novel Non-Invasive Aid for Bladder Cancer Monitoring

The innovative Arquer Diagnostic urine test for bladder cancer adds recurrence monitoring to the approved indications Sunderland, January 22nd 2019 ...
Read More